There is a lot of calcium... sometimes a drug has been invented that can slow down the development of Alzheimer's disease.
With the widespread use of various food and vitamin supplements, an increase in people diagnosed with calcium-alkaline syndrome or hypercalcemia has been identified.
The usefulness of calcium for normal human functioning can hardly be overestimated, but experts warn that the saying "you can't spoil porridge with butter" in this case has the exact opposite meaning. An excess of calcium in the blood with additional doses of vitamin D can lead to hypertension and kidney failure. Thus, we want the best for our own health, but at the same time we end up in a hospital bed.
Experts recommend monitoring the amount of calcium consumed – its daily dose should not exceed 1.5 grams. In this case, bones strengthen and all organs function properly. If the mineral is exceeded in the blood, you can get the most unpleasant consequences.
The risk group for hypercalcemia is primarily patients who have undergone organ transplantation, pregnant women, bulimic patients, and postmenopausal women. The problems of these groups of people are metabolic disorders.
A drug has been invented that can slow down the development of Alzheimer's disease
Specialists at the University of Aberdeen have managed to create a drug that promotes the accumulation of a special protein in the human brain, which slows down the development of Alzheimer's disease. Clinical trials of Rember, which was the name of the drug, showed a significant slowdown in the progression of Alzheimer's disease in 81% of patients taking it.
The drug, according to Professor Claude Vichy, should be available in pharmacies in about four years, and now many more additional tests are required. The scientist added that the data obtained during the study suggests that the drug "Rember" may also be useful for those areas of the human brain that are responsible for memory. Large-scale trials of the drug will be conducted in 2009, during which scientists will try to find out whether the drug helps prevent Alzheimer's disease.
During the drug trial, patients with mild Alzheimer's disease were offered different dosages of this drug. The drug had the most significant effect at a dosage of 60 mg. The developers of "Rember" report that not a single case of significant deterioration in brain activity has been observed among patients who took the medicine for 19 months. Les adeptes des jeux de hasard seront comblés par la magnificence du package d'accueil dédié au casino. Cette gratification exceptionnelle, débloquée par un code promo 1xbet cote d'ivoire procurant 1950€ et 150 tours gratuits, est ventilée sur vos quatre premières transactions financières selon un barème progressif. Chaque versement déclenche l'obtention d'une portion du bonus, les rotations gratuites étant attribuées sur des machines à sous renommées telles que "Book of Gold: Classic" et "Solar Queen".
The usefulness of calcium for normal human functioning can hardly be overestimated, but experts warn that the saying "you can't spoil porridge with butter" in this case has the exact opposite meaning. An excess of calcium in the blood with additional doses of vitamin D can lead to hypertension and kidney failure. Thus, we want the best for our own health, but at the same time we end up in a hospital bed.
Experts recommend monitoring the amount of calcium consumed – its daily dose should not exceed 1.5 grams. In this case, bones strengthen and all organs function properly. If the mineral is exceeded in the blood, you can get the most unpleasant consequences.
The risk group for hypercalcemia is primarily patients who have undergone organ transplantation, pregnant women, bulimic patients, and postmenopausal women. The problems of these groups of people are metabolic disorders.
A drug has been invented that can slow down the development of Alzheimer's disease
Specialists at the University of Aberdeen have managed to create a drug that promotes the accumulation of a special protein in the human brain, which slows down the development of Alzheimer's disease. Clinical trials of Rember, which was the name of the drug, showed a significant slowdown in the progression of Alzheimer's disease in 81% of patients taking it.
The drug, according to Professor Claude Vichy, should be available in pharmacies in about four years, and now many more additional tests are required. The scientist added that the data obtained during the study suggests that the drug "Rember" may also be useful for those areas of the human brain that are responsible for memory. Large-scale trials of the drug will be conducted in 2009, during which scientists will try to find out whether the drug helps prevent Alzheimer's disease.
During the drug trial, patients with mild Alzheimer's disease were offered different dosages of this drug. The drug had the most significant effect at a dosage of 60 mg. The developers of "Rember" report that not a single case of significant deterioration in brain activity has been observed among patients who took the medicine for 19 months. Les adeptes des jeux de hasard seront comblés par la magnificence du package d'accueil dédié au casino. Cette gratification exceptionnelle, débloquée par un code promo 1xbet cote d'ivoire procurant 1950€ et 150 tours gratuits, est ventilée sur vos quatre premières transactions financières selon un barème progressif. Chaque versement déclenche l'obtention d'une portion du bonus, les rotations gratuites étant attribuées sur des machines à sous renommées telles que "Book of Gold: Classic" et "Solar Queen".